Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 243

1.

Case-control analysis identifies shared properties of rare germline variation in cancer predisposing genes.

Artomov M, Joseph V, Tiao G, Thomas T, Schrader K, Klein RJ, Kiezun A, Gupta N, Margolin L, Stratigos AJ, Kim I, Shannon K, Ellisen LW, Haber D, Getz G, Tsao H, Lipkin SM, Altshuler D, Offit K, Daly MJ.

Eur J Hum Genet. 2019 Feb 4. doi: 10.1038/s41431-019-0346-0. [Epub ahead of print]

PMID:
30718883
2.

Growth suppression by dual BRAF(V600E) and NRAS(Q61) oncogene expression is mediated by SPRY4 in melanoma.

Kumar R, Njauw CN, Reddy BY, Ji Z, Rajadurai A, Klebanov N, Tsao H.

Oncogene. 2019 Jan 16. doi: 10.1038/s41388-018-0632-2. [Epub ahead of print]

PMID:
30651601
3.

Use of Targeted Next-Generation Sequencing to Identify Activating Hot Spot Mutations in Cherry Angiomas.

Klebanov N, Lin WM, Artomov M, Shaughnessy M, Njauw CN, Bloom R, Eterovic AK, Chen K, Kim TB, Tsao SS, Tsao H.

JAMA Dermatol. 2019 Jan 2. doi: 10.1001/jamadermatol.2018.4231. [Epub ahead of print]

PMID:
30601876
4.

Factors associated with suspected nonmelanoma skin cancers, dysplastic nevus, and cutaneous melanoma among first-time SPOTme screening program participants (2009-2010).

Beaulieu D, Tsao H, Michaud DS, Okhovat JP, Halpern AC, Geller AC.

J Am Acad Dermatol. 2018 Dec 10. pii: S0190-9622(18)33052-4. doi: 10.1016/j.jaad.2018.12.010. [Epub ahead of print]

PMID:
30543833
5.

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, de la Fouchardière A, Cabaret O, Golmard L, Stoppa-Lyonnet D, Garfield E, Njauw CN, Cheung M, Turunen JA, Repo P, Järvinen RS, van Doorn R, Jager MJ, Luyten GPM, Marinkovic M, Chau C, Potrony M, Höiom V, Helgadottir H, Pastorino L, Bruno W, Andreotti V, Dalmasso B, Ciccarese G, Queirolo P, Mastracci L, Wadt K, Kiilgaard JF, Speicher MR, van Poppelen N, Kilic E, Al-Jamal RT, Dianzani I, Betti M, Bergmann C, Santagata S, Dahiya S, Taibjee S, Burke J, Poplawski N, O'Shea SJ, Newton-Bishop J, Adlard J, Adams DJ, Lane AM, Kim I, Klebe S, Racher H, Harbour JW, Nickerson ML, Murali R, Palmer JM, Howlie M, Symmons J, Hamilton H, Warrier S, Glasson W, Johansson P, Robles-Espinoza CD, Ossio R, de Klein A, Puig S, Ghiorzo P, Nielsen M, Kivelä TT, Tsao H, Testa JR, Gerami P, Stern MH, Paillerets BB, Abdel-Rahman MH, Hayward NK.

J Natl Cancer Inst. 2018 Dec 1;110(12):1328-1341. doi: 10.1093/jnci/djy171.

PMID:
30517737
6.

Guidelines of care for the management of primary cutaneous melanoma.

Swetter SM, Tsao H, Bichakjian CK, Curiel-Lewandrowski C, Elder DE, Gershenwald JE, Guild V, Grant-Kels JM, Halpern AC, Johnson TM, Sober AJ, Thompson JA, Wisco OJ, Wyatt S, Hu S, Lamina T.

J Am Acad Dermatol. 2019 Jan;80(1):208-250. doi: 10.1016/j.jaad.2018.08.055. Epub 2018 Nov 1.

PMID:
30392755
7.

Clinical spectrum of cutaneous melanoma morphology.

Klebanov N, Gunasekera NS, Lin WM, Hawryluk EB, Miller DM, Reddy BY, Christman MP, Beaulieu D, Rajadurai S, Duncan LM, Sober AJ, Tsao H.

J Am Acad Dermatol. 2019 Jan;80(1):178-188.e3. doi: 10.1016/j.jaad.2018.08.028. Epub 2018 Aug 28.

PMID:
30165162
8.

The first 30 years of the American Academy of Dermatology skin cancer screening program: 1985-2014.

Okhovat JP, Beaulieu D, Tsao H, Halpern AC, Michaud DS, Shaykevich S, Geller AC.

J Am Acad Dermatol. 2018 Nov;79(5):884-891.e3. doi: 10.1016/j.jaad.2018.05.1242. Epub 2018 Jul 26.

PMID:
30057360
9.

Evaluating LC-MS/MS To Measure Accumulation of Compounds within Bacteria.

Iyer R, Ye Z, Ferrari A, Duncan L, Tanudra MA, Tsao H, Wang T, Gao H, Brummel CL, Erwin AL.

ACS Infect Dis. 2018 Sep 14;4(9):1336-1345. doi: 10.1021/acsinfecdis.8b00083. Epub 2018 Jul 13.

PMID:
29961312
10.

CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.

Karagianni F, Njauw CN, Kypreou KP, Stergiopoulou A, Plaka M, Polydorou D, Chasapi V, Pappas L, Stratigos IA, Champsas G, Panagiotou P, Gogas H, Evangelou E, Tsao H, Stratigos AJ, Stefanaki I.

Acta Derm Venereol. 2018 Oct 10;98(9):862-866. doi: 10.2340/00015555-2969.

11.

Shoulder Taping and Neuromuscular Control.

Snodgrass SJ, Farrell SF, Tsao H, Osmotherly PG, Rivett DA, Chipchase LS, Schabrun SM.

J Athl Train. 2018 Apr;53(4):395-403. doi: 10.4085/1062-6050-68-17. Epub 2018 Mar 23.

PMID:
29569944
12.

Contrasting features of childhood and adolescent melanomas.

Bartenstein DW, Kelleher CM, Friedmann AM, Duncan LM, Tsao H, Sober AJ, Hawryluk EB.

Pediatr Dermatol. 2018 May;35(3):354-360. doi: 10.1111/pde.13454. Epub 2018 Mar 23.

PMID:
29569376
13.

Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing.

Artomov M, Stratigos AJ, Kim I, Kumar R, Lauss M, Reddy BY, Miao B, Daniela Robles-Espinoza C, Sankar A, Njauw CN, Shannon K, Gragoudas ES, Marie Lane A, Iyer V, Newton-Bishop JA, Timothy Bishop D, Holland EA, Mann GJ, Singh T, Daly MJ, Tsao H.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx083.

14.

High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.

Eliades P, Abraham BJ, Ji Z, Miller DM, Christensen CL, Kwiatkowski N, Kumar R, Njauw CN, Taylor M, Miao B, Zhang T, Wong KK, Gray NS, Young RA, Tsao H.

J Invest Dermatol. 2018 Jul;138(7):1582-1590. doi: 10.1016/j.jid.2017.09.056. Epub 2018 Feb 8.

15.

Cutaneous Presentation of Mesothelioma With a Sarcomatoid Transformation.

Klebanov N, Reddy BY, Husain S, Silvers DN, Grossman ME, Tsao H.

Am J Dermatopathol. 2018 May;40(5):378-382. doi: 10.1097/DAD.0000000000001023.

PMID:
29059099
16.

Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.

Haugh AM, Njauw CN, Bubley JA, Verzì AE, Zhang B, Kudalkar E, VandenBoom T, Walton K, Swick BL, Kumar R, Rana HQ, Cochrane S, McCormick SR, Shea CR, Tsao H, Gerami P.

JAMA Dermatol. 2017 Oct 1;153(10):999-1006. doi: 10.1001/jamadermatol.2017.2330. Review.

17.

Somatic driver mutations in melanoma.

Reddy BY, Miller DM, Tsao H.

Cancer. 2017 Jun 1;123(S11):2104-2117. doi: 10.1002/cncr.30593. Review.

18.

Cutaneous melanoma in women.

Roh MR, Eliades P, Gupta S, Grant-Kels JM, Tsao H.

Int J Womens Dermatol. 2017 Feb 16;3(1 Suppl):S11-S15. doi: 10.1016/j.ijwd.2017.02.003. eCollection 2017 Mar. Review.

19.

Introduction to JID's Landmarks in the Molecular Revolution.

Tsao H.

J Invest Dermatol. 2017 May;137(5):996. doi: 10.1016/j.jid.2017.03.005. No abstract available.

20.

Quantitative Prediction of CYP3A4 Induction: Impact of Measured, Free, and Intracellular Perpetrator Concentrations from Human Hepatocyte Induction Studies on Drug-Drug Interaction Predictions.

Sun Y, Chothe PP, Sager JE, Tsao H, Moore A, Laitinen L, Hariparsad N.

Drug Metab Dispos. 2017 Jun;45(6):692-705. doi: 10.1124/dmd.117.075481. Epub 2017 Mar 23.

PMID:
28336578

Supplemental Content

Loading ...
Support Center